Sareetha Kailayangiri

*This is an algorithmically generated author record based on publicly available information.

Research Subjects

Research Interests

Sareetha Kailayangiri has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

Claudia Rossig
Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
21 shared publications
Bianca Altvater
Department of Pediatric Hematology and Oncology, University Children’s Hospital Muenster, 48149 Muenster, Germany
19 shared publications
Wolfgang Hartmann
Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany
17 shared publications
Andreas Mackensen
University Hospital of Erlangen
16 shared publications
Dennis Görlich
Institute of Biostatistics and Clinical Research, University of Münster, 48149 Münster, Germany
16 shared publications
Simon Völkl
Department of Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen
16 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Supplementary Materials and Methods
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Supplementary Materials and Methods
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Bioluminescence images 14 days after injection of luciferasetransduced CHLA-255 tumor cells
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S2 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Bioluminescence images 14 days after injection of luciferasetransduced CHLA-255 tumor cells
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
GD2IL18CART tolerability experiment
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
GD2IL18CART tolerability experiment
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Absolute numbers of T cells and IL-18 concentrations during manufacturing
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Absolute numbers of T cells and IL-18 concentrations during manufacturing
Open Access
Website
Google Scholar
Cited by 1
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
GD2 expression in cell lines after genome editing
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
GD2 expression in cell lines after genome editing
Cited by 1
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Dose-dependence of xenogeneic GvHD in mice receiving GD2IL18CART
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Dose-dependence of xenogeneic GvHD in mice receiving GD2IL18CART
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Supplementary Materials and Methods
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Supplementary Materials and Methods
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
GD2IL18CART tolerability experiment
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
GD2IL18CART tolerability experiment
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Dose-dependence of xenogeneic GvHD in mice receiving GD2IL18CART
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Dose-dependence of xenogeneic GvHD in mice receiving GD2IL18CART
Open Access
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Absolute numbers of T cells and IL-18 concentrations during manufacturing
Website
Google Scholar
- 15 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
by Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, et al.
Absolute numbers of T cells and IL-18 concentrations during manufacturing

Show all